Newsbenzinga
Insmed Raises FY2026 Sales Guidance from $1.450B-$1.470B to $1.700B-$1.870B vs $1.705B Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…